3 results
Measures of suicidality in phase 3 clinical trials of levomilnacipran ER in adults with major depressive disorder
-
- Journal:
- CNS Spectrums / Volume 22 / Issue 6 / December 2017
- Published online by Cambridge University Press:
- 19 May 2017, pp. 475-483
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
The efficacy of levomilnacipran ER across symptoms of major depressive disorder: a post hoc analysis of 5 randomized, double-blind, placebo-controlled trials
-
- Journal:
- CNS Spectrums / Volume 21 / Issue 5 / October 2016
- Published online by Cambridge University Press:
- 13 June 2016, pp. 385-392
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials
-
- Journal:
- CNS Spectrums / Volume 20 / Issue 2 / April 2015
- Published online by Cambridge University Press:
- 05 June 2014, pp. 148-156
-
- Article
-
- You have access
- Open access
- HTML
- Export citation